Clinical and Molecular Hepatology

Aims & Scope

Clinical and Molecular Hepatology (Clin Mol Hepatol), is an international, peer-reviewed, open- access journal published quarterly in English.

Clin Mol Hepatol aims to share advanced and latest knowledge, trend, and understanding of hepatobiliary diseases, to provide a wide open academic forum for active debate and discussion among clinical doctors, translational researchers, and basic scientists, and to improve public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific area with high prevalence of B viral infection and hepatocellular carcinoma.

In addition, Clin Mol Hepatol gives priority to epidemiological studies of hepatobiliary diseases in East Asia, North Asia, Southeast Asia, Central Asia, South Asia, Southwest Asia, Pacific, Africa, Central Europe, Eastern Europe, Central America, and South America.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• PubMed
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,000,000.00 KRW. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Cost-of-illness studies: concepts, scopes, and methods

  Citation: 546

  Authors: Changik

• Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

  Citation: 474

  Authors: Yee Hui, Jamil S., Wee Han, Peng-Sheng, Hirsh, Aarshi, Walid, Ju Dong, Omer, Brennan, Alexander

• Global incidence and prevalence of nonalcoholic fatty liver disease

  Citation: 437

  Authors: Margaret LP, Cheng Han, Daniel Q., Kai En, Darren JH, Wen Hui, Ju Dong, Eunice, Mark D.

• Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis

  Citation: 343

  Authors: Seung-Hoi

• MAFLD: How is it different from NAFLD?

  Citation: 290

  Authors: Cameron, Yadhavan, Ming-Hua, Jacob

• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

  Citation: 227

  Authors:

• A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

  Citation: 226

  Authors: Su Jong

• KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

  Citation: 210

  Authors: Seong Hee, Hye Won, Jeong-Ju, Yuri, Seung Up, Tae Hee, Byoung Kuk, Sang Gyune, Sang Bong, Haeryoung, Dae Won, Joon-Il, Do Seon, Won, Soung Won, Moon Young, Hong, Sujin, Jin-Woo, Yong Kyun

• Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

  Citation: 207

  Authors: Michael H., Yee Hui, Biyao, Scott, Linda, Ramsey, Mindie H.

• Genetic predisposition in nonalcoholic fatty liver disease

  Citation: 185

  Authors: Silvia, Carlos J.